SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

344.5797109

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

45.47

8339.79

EPS(TTM)

Face Value()

Div & Yield %

19.9

0.44

Back

BCL Enterprises reports standalone net loss of Rs 0.06 crore in the September 2025 quarter

Nov 15,2025

Net loss of BCL Enterprises reported to Rs 0.06 crore in the quarter ended September 2025 as against net profit of Rs 0.57 crore during the previous quarter ended September 2024. Sales declined 89.85% to Rs 0.27 crore in the quarter ended September 2025 as against Rs 2.66 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.27	2.66	-90
OPM %	-3.70	22.56	-
PBDT	-0.03	0.72	PL
PBT	-0.04	0.71	PL
NP	-0.06	0.57	PL

74,532.96 325.72 ( 0.44%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)